ExtraLife
The Hypothesis
This is the novel research question that should make stem cell researchers pay attention.
“What if pre-treating patients with BPC-157 and TB-500 for 4–6 weeks before stem cell therapy significantly improves engraftment, survival, and therapeutic outcomes?”
Research-phase · Preclinical evidenceUpregulates growth factor receptors and promotes angiogenesis — creating new blood vessel networks that stem cells need to survive and integrate.
Promotes cell migration and differentiation — guiding stem cells to where they’re needed and helping them become functional tissue.
Together, these peptides may create an optimal tissue environment for stem cells to thrive — reduced inflammation, improved blood supply, upregulated growth factor receptors. This hypothesis is being investigated through the ExtraLife Collective — our community-funded research network.
A new class of mitochondrial-derived peptides — Humanin (HNG), MOTS-c, and SS-31 (Elamipretide) — may complement stem cell therapy by protecting transplanted cells from oxidative stress. Published research shows direct protective effects on cochlear hair cells (Cortada et al., 2024; Waldmann et al., 2023), with SS-31 demonstrating mitochondrial-specific accumulation in cochlear hair cells (Nyberg et al., 2021).
H₂ Research
The one molecule that can reach where most drugs cannot.
Molecular hydrogen (H₂) penetrates the blood-labyrinth barrier — something most pharmaceutical compounds cannot do. Published research shows H₂ inhalation preserves outer hair cells, protects synaptic structures, and reduces oxidative stress in the cochlea.
Our hypothesis: combining H₂ inhalation with stem cell therapy creates a dual protective environment — H₂ reduces the oxidative stress that kills transplanted cells while stem cells work to regenerate damaged tissue.
H₂ preserved outer hair cells in noise-exposed models — direct cochlear protection through the blood-labyrinth barrier
Human RCT: H₂-enriched saline improved hearing thresholds (39 dB vs 49.5 dB in controls, p < 0.05)
Significantly higher outer hair cell survival rates with hydrogen-rich water following noise exposure
H₂ inhalation is now available at our partner facility, Eminent Wellness in Scottsdale.
AI Research
Pattern recognition across hundreds of participants — in real time.
Monitors 200+ research sources across 12 languages daily. Identifies patterns across anonymized participant data that no individual researcher could see.
Imagine: 500 Collective members running variations of a stem cell + peptide protocol. Claudia analyzes every data point — biomarkers, THI scores, audiograms, HRV — and identifies which combinations work best for which patient profiles.
Biomarkers
Blood panels & inflammatory markers
THI Scores
Weekly tinnitus severity tracking
Audiograms
Objective hearing measurements
HRV
Autonomic nervous system data
This is not a clinical trial. It’s a continuously learning research network.
Why Tinnitus First?
Research funding for tinnitus is a fraction of what it should be. But the science is promising: stem cell therapy, peptide protocols, molecular hydrogen, psychedelic-assisted treatments — the pieces exist. They’ve just never been connected.
ExtraLife is connecting them. Starting with tinnitus. Expanding from there.
Founded by Justin Gurian, who lives with tinnitus, and Dr. Sara Ameli, physician and peptide researcher.
The Collective
Community-funded, open-access research. No crypto required.
BPC-157
Active Bounty
Research-phase · Preclinical evidenceStem Cell Therapy
Active Bounty
InvestigationalPsilocybin
Active Bounty
Investigational · Jurisdiction-dependentPeptide Protocols
Active Bounty
ExtraLife hypothesis · Under investigationAI Discovery
Active Bounty
Molecular Hydrogen
Active Bounty
Emerging evidence · Clinical trials ongoingThe Team
Co-Founder & CMO
Physician and peptide researcher. Leading ExtraLife’s clinical research strategy and protocol design.
Co-Founder & Director of AI Research
Lives with tinnitus. Building the AI infrastructure to accelerate hearing research from personal necessity.
Multi-Agent Health Intelligence
24/7 research monitoring across 12 languages. Pattern recognition at a scale no human team could match.
Continue the Conversation